β-cell deletion of the PKm1 and PKm2 isoforms of pyruvate kinase in mice reveal their essential role as nutrient sensors for the KATP channel

  1. Hannah R Foster
  2. Thuong Ho
  3. Evgeniy Potapenko
  4. Sophia M Sdao
  5. Shih Ming Huang
  6. Sophie L Lewandowski
  7. Halena R VanDeusen
  8. Shawn M Davidson
  9. Rebecca L Cardone
  10. Marc Prentki
  11. Richard G Kibbey
  12. Matthew J Merrins  Is a corresponding author
  1. University of Wisconsin-Madison, United States
  2. Massachusetts Institute of Technology, United States
  3. Yale University, United States
  4. University of Montreal, Canada

Abstract

Pyruvate kinase (PK) and the phosphoenolpyruvate (PEP) cycle play key roles in nutrient-stimulated KATP channel closure and insulin secretion. To identify the PK isoforms involved, we generated mice lacking β-cell PKm1, PKm2, and mitochondrial PEP carboxykinase (PCK2) that generates mitochondrial PEP. Glucose metabolism generates both glycolytic and mitochondrially-derived PEP, which triggers KATP closure through local PKm1 and PKm2 signaling at the plasma membrane. Amino acids, which generate mitochondrial PEP without producing glycolytic fructose 1,6-bisphosphate to allosterically activate PKm2, signal through PKm1 to raise ATP/ADP, close KATP channels, and stimulate insulin secretion. Raising cytosolic ATP/ADP with amino acids is insufficient to close KATP channels in the absence of PK activity or PCK2, indicating that KATP channels are primarily regulated by PEP that provides ATP via plasma membrane-associated PK, rather than mitochondrially-derived ATP. Following membrane depolarization, the PEP cycle is also involved in an 'off-switch' that facilitates KATP channel reopening and Ca2+ extrusion, as shown by PK activation experiments and β-cell PCK2 deletion, which prolongs Ca2+ oscillations and increases insulin secretion. In conclusion, the differential response of PKm1 and PKm2 to the glycolytic and mitochondrial sources of PEP influences the β-cell nutrient response, and controls the oscillatory cycle regulating insulin secretion.

Data availability

Datasets generated or analyzed in this study are included in the manuscript and supporting files. Source data files are provided for Figures 1-6 and the associated figure supplement files.

Article and author information

Author details

  1. Hannah R Foster

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Thuong Ho

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Evgeniy Potapenko

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Sophia M Sdao

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Shih Ming Huang

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Sophie L Lewandowski

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Halena R VanDeusen

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Shawn M Davidson

    Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Rebecca L Cardone

    Department of Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Marc Prentki

    Department of Nutrition, University of Montreal, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Richard G Kibbey

    Department of Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Matthew J Merrins

    Department of Medicine, University of Wisconsin-Madison, Madison, United States
    For correspondence
    merrins@wisc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1599-9227

Funding

National Institutes of Health (R01DK113103)

  • Matthew J Merrins

National Institutes of Health (R01DK113103)

  • Matthew J Merrins

U.S. Department of Veterans Affairs (I01B005113)

  • Matthew J Merrins

Health Resources and Services Administration (T32HP10010)

  • Hannah R Foster

National Institutes of Health (T32AG000213)

  • Hannah R Foster

National Institutes of Health (T32DK007665)

  • Sophie L Lewandowski

American Diabetes Association (1-17-PDF-155)

  • Halena R VanDeusen

National Institutes of Health (R01AG062328)

  • Matthew J Merrins

National Institutes of Health (R01DK127637)

  • Richard G Kibbey

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experiments were conducted under the supervision of the IACUC of the William S. Middleton Memorial Veterans Hospital (Protocol: MJM0001).

Copyright

© 2022, Foster et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,032
    views
  • 459
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hannah R Foster
  2. Thuong Ho
  3. Evgeniy Potapenko
  4. Sophia M Sdao
  5. Shih Ming Huang
  6. Sophie L Lewandowski
  7. Halena R VanDeusen
  8. Shawn M Davidson
  9. Rebecca L Cardone
  10. Marc Prentki
  11. Richard G Kibbey
  12. Matthew J Merrins
(2022)
β-cell deletion of the PKm1 and PKm2 isoforms of pyruvate kinase in mice reveal their essential role as nutrient sensors for the KATP channel
eLife 11:e79422.
https://doi.org/10.7554/eLife.79422

Share this article

https://doi.org/10.7554/eLife.79422

Further reading

    1. Cell Biology
    Zewei Zhao, Longyun Hu ... Zhonghan Yang
    Research Article

    The induction of adipose thermogenesis plays a critical role in maintaining body temperature and improving metabolic homeostasis to combat obesity. β3-adrenoceptor (β3-AR) is widely recognized as a canonical β-adrenergic G-protein-coupled receptor (GPCR) that plays a crucial role in mediating adipose thermogenesis in mice. Nonetheless, the limited expression of β3-AR in human adipocytes restricts its clinical application. The objective of this study was to identify a GPCR that is highly expressed in human adipocytes and to explore its potential involvement in adipose thermogenesis. Our research findings have demonstrated that the adhesion G-protein-coupled receptor A3 (ADGRA3), an orphan GPCR, plays a significant role in adipose thermogenesis through its constitutively active effects. ADGRA3 exhibited high expression levels in human adipocytes and mouse brown fat. Furthermore, the knockdown of Adgra3 resulted in an exacerbated obese phenotype and a reduction in the expression of thermogenic markers in mice. Conversely, Adgra3 overexpression activated the adipose thermogenic program and improved metabolic homeostasis in mice without exogenous ligand. We found that ADGRA3 facilitates the biogenesis of beige human or mouse adipocytes in vitro. Moreover, hesperetin was identified as a potential agonist of ADGRA3, capable of inducing adipocyte browning and ameliorating insulin resistance in mice. In conclusion, our study demonstrated that the overexpression of constitutively active ADGRA3 or the activation of ADGRA3 by hesperetin can induce adipocyte browning by Gs-PKA-CREB axis. These findings indicate that the utilization of hesperetin and the selective overexpression of ADGRA3 in adipose tissue could serve as promising therapeutic strategies in the fight against obesity.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bethany M Bartlett, Yatendra Kumar ... Wendy A Bickmore
    Research Article Updated

    During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.